glp 1 inhibitors weight loss GLP-1 receptor agonists How GLP-1 Medications Boost Weight

Anti-obesity and anti-hyperglycemic effects of cinnamaldehyde via altered ghrelin secretion and functional impact on food intake and gastric emptying

A recent analysis indicates that these drugs weaken the usual link between impulsive tendencies and aggressive actions

Hydrate and supplement as needed: Water and key nutrients are non-negotiable for long-term health

High-resolution LC-MS techniques enable precise molecular weight confirmation, peptide mapping, and structural characterization of GLP-1 therapeutics

Prinz M, Masuda T, Wheeler MA, Quintana FJ

FDA Safety Announcement: Soliqua FDA Safety Label Change and Revised Drug Label Trulicity (active ingredient: dulaglutide) subcutaneous injection Initial FDA Approval: 2014 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting